Assoc. Prof. Dr. Iyikesici specializes in metabolically supported chemotherapy – a tailored approach combining traditional methods with metabolic therapies at Central Hospital.

• Focuses on breast, lung, and gastrointestinal cancers
• Pioneers metabolic therapies like ketogenic diet in treatment plans
• Published peer-reviewed research on cancer treatment outcomes
• Offers hyperthermia and hyperbaric oxygen as complementary therapies

With over 20 years of oncology expertise, Dr. Lucía González Cortijo leads Quironsalud Madrid's oncology department and specializes in breast and gynecologic cancers.

• Focuses on personalized treatments, including immunotherapy and targeted therapies
• Principal investigator in 20+ clinical trials for breast cancer
• Member of ESMO, ASCO, and GEICAM research groups
• Founder of 'Corre en Rosa' to support cancer patients through physical activity
• Trained at MD Anderson Cancer Center Madrid

Dr. Ivetta Danylesko specializes in chemotherapy at Sheba Medical Center, bringing expert care tailored to individual patient needs.

• Specializes in chemotherapy protocols
• Practices at Sheba Medical Center, a top-tier facility
• Focuses on personalized treatment approaches

Clinical Director of a Multidisciplinary Breast Unit with 322 peer-reviewed publications – Dr. Kuemmel leads breast cancer research at Kliniken Essen-Mitte.

• Executive Board Member of the AGO (Arbeitsgemeinschaft Gynäkologische Onkologie)
• ESMO Faculty member for Breast Cancer
• Global PI and head of 27 clinical investigations and trials
• Member of multiple prestigious oncology societies including ESMO and ASCO

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Zhevelyuk specializes in oncology and radiology at Assuta Medical Center.

• Experienced in chemotherapy treatments
• Works at a leading medical center
• Focuses on patient-centered care

Uzm. Dr. Erkan Göcen is a Radiation Oncology Specialist at Çerkezköy Private Optimed Hospital (Optimed Health Group). He graduated from İstanbul University, İstanbul Faculty of Medicine (Çapa) in 2003.

Career: He trained and practiced in Radiation Oncology from 2010 to 2012. He worked in public and private health institutions from 2012 to 2016. He served in the private medical sector as a Radiation Oncology Specialist from 2016 to 2023. He has been at Optimed Hospital since 2024.

Clinical interests: cancers of the brain, head and neck, esophagus, stomach, colorectal, pancreas, prostate, bladder, lung, soft tissues (sarcomas), skin, uterus and cervix, and breast. Affiliations: Turkish Society for Radiation Oncology (TROD) and Tekirdağ Medical Chamber. Languages: English and Turkish.

Leading expert in chronic lymphocytic leukemia (CLL) – Professor Bosch has pioneered new treatments and technologies for hematological diseases.

• Conducts over 80 clinical trials from phase 1 to phase 3
• Published more than 100 articles in top medical journals
• Head of Hematology at IOB Institute of Oncology
• President of the Spanish group for CLL study (GELLC)

Dr. Spielberg is a specialized oncohematologist treating patients at Assuta Medical Center.

• Focuses exclusively on chemotherapy treatments
• Works at one of Israel's leading medical centers
• Dedicated to personalized treatment plans for each patient

Principal Investigator in clinical trials for ovarian, cervical, and endometrial cancer – Dr. Oaknin leads groundbreaking research at Hospital Quiron Barcelona.

• Author of 100+ publications on gynecological tumors
• Executive board member of GEICO Group (Spanish Ovarian Cancer Research Group)
• Faculty member for Gyn-Track in ESMO
• Spanish representative in GCIG Group's Cervical Committee

Specializes in breast cancer and melanoma treatments, focusing on hormone therapy resistance and immunotherapy. Works at Hospital Quiron Barcelona.

• Participated in trials leading to new drug approvals for breast cancer
• Involved in studies that revolutionized melanoma treatment
• Member of Breast Cancer and Melanoma Units at Vall d’Hebron
• Focuses on holistic patient care

Dr. Prat leads SOLTI as president, designing clinical trials for breast cancer treatments. His research focuses on gene expression and molecular subtypes.

• Head of Translational Genomics and Targeted Therapeutics at IDIBAPS
• Co-founder of Reveal Genomics, holds three patents
• Over 160 publications with an H-Index of 51
• Medical oncology fellowship at Vall d´Hebron Institute of Oncology
• Tenure-Track Professor at Barcelona University

Dr. Graus is a leading expert in paraneoplastic neurological syndromes, having defined the first strict diagnostic criteria for these conditions.

• 44 years of experience of experience in neuro-oncology
• Former Chief of Neurology at Hospital Clinic Barcelona
• Founder and past president of the European Association of Neuro-Oncology
• Specializes in neurotoxicities from cancer treatments
• Honorary doctorate from Lyon University

Specialized in gynecological oncology and chemotherapy at Samsung Medical Center.

• Focused expertise in gynecological cancers and chemotherapy treatments
• Works at Samsung Medical Center, a leading healthcare institution
• Oncogynecologist with a strong background in women's cancer care

Israel's leading specialist in lung cancer immunotherapy – Prof. Peled heads the Thoracic Cancer Unit at Davidoff Cancer Center.

• Fellowship-trained in lung cancer at University of Colorado Denver
• Received MERIT award from American Society of Clinical Oncology (ASCO)
• Chairs IASLC's Early Detection & Prevention Committee
• Specializes in personalized medicine and immuno-oncology for lung cancer

Internationally recognized pediatric oncology expert – Prof. Ben-Harush leads the Pediatric Division at Ruth Rappaport Children's Hospital.

• Specializes in pediatric oncology and bone marrow transplantation
• Recipient of the Chevalier de la Legion d'Honneur in France
• Named one of the world's most caring doctors by the World Medical Association
• Member of children's oncology groups in the USA and Europe

Head of the Breast Cancer Treatment Center – Prof. Jablonski-Perec brings decades of specialized expertise to Hadassah Medical Center.

• Received medical training at Sloan-Kettering Cancer Center in New York
• Professor of Oncology at Hebrew University since 2006
• Former Head of the Institute of Oncology
• Member of multiple international cancer societies

Radiotherapy specialist with a dedicated focus on oncology at Rambam Medical Center.

• Specializes in chemotherapy and radiotherapy treatments
• Works at Rambam Medical Center, a leading healthcare institution
• Committed to personalized cancer care plans